Home Compliance Radeas to to Pay $11.6 Million for Fraudulent Billing and Kickbacks in... ComplianceNews Radeas to to Pay $11.6 Million for Fraudulent Billing and Kickbacks in Unnecessary Drug Testing Scheme April 8, 2022 65 Share FacebookLinkedinTwitter cawee | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance DOJ’s First Intervention in Cybersecurity FCA Qui Tam Case Signals Continued Cyber Enforcement Compliance Relator Alleged Violation of Statutes But Didn’t Adequately Plead False Certification Compliance Heed the Warning from DOJ to Strengthen Compliance Programs